Amalgamated Bank’s MyoKardia, Inc. Common Stock MYOK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q4
Sell
-7,451
Closed -$1.02M 1607
2020
Q3
$1.02M Sell
7,451
-43
-0.6% -$4.57K 0.04% 434
2020
Q2
$724K Sell
7,494
-446
-6% -$37.2K 0.03% 597
2020
Q1
$372K Sell
7,940
-225
-3% -$14.4K 0.01% 1048
2019
Q4
$595K Buy
8,165
+310
+4% +$18.8K 0.01% 1038
2019
Q3
$410K Sell
7,855
-117
-1% -$6.22K 0.01% 1150
2019
Q2
$400K Buy
7,972
+2,810
+54% +$137K 0.01% 1200
2019
Q1
$268K Buy
5,162
+147
+3% +$6.77K 0.01% 1334
2018
Q4
$245K Buy
+5,015
New +$276K 0.01% 1297
2018
Q3
Sell
-4,657
Closed -$231K 1690
2018
Q2
$231K Buy
+4,657
New +$225K 0.01% 1478

Amalgamated Bank's MYOK Position: Q4 2020 in Review

Amalgamated Bank sold out of MyoKardia, Inc. Common Stock (MYOK) in Q4 2020, closing a stake of 7,451 shares — an estimated $1.02M sold.

Amalgamated Bank first reported a position in MYOK in Q2 2018 and held it in 9 quarters. The position peaked at $1.02M in Q3 2020. 0 funds tracked by Wall St. Rank hold MYOK as of Q4 2020.

  • Amalgamated Bank reported no remaining MyoKardia, Inc. Common Stock position as of Q4 2020 after selling out during the quarter.
  • Amalgamated Bank sold 7,451 MyoKardia, Inc. Common Stock shares in Q4 2020, an estimated $1.02M.
  • Amalgamated Bank first reported a position in MyoKardia, Inc. Common Stock in Q2 2018 and held it in 9 quarters.
  • Amalgamated Bank's MyoKardia, Inc. Common Stock position peaked at $1.02M in Q3 2020.
  • 0 funds tracked by Wall St. Rank held MyoKardia, Inc. Common Stock as of Q4 2020.

Based on Amalgamated Bank's 13F filing for Q4 2020, filed 12 Feb 2021.